GlassScriptPhysician profile
Kenneth Koury
NPI 1376855643
$5,200.84
in general payments reported to CMS, 2019-2025
10 companies · $1,376 in 2025
The $1,376 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2021: $217 · 2022: $1,996 · 2023: $375 · 2024: $602 · 2025: $1,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,251 · Travel and Lodging: $1,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.76 |
| Travel and Lodging | $1,102.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,954.07 | 2019-2025 | Gamma, Axsos, Dall-Miles |
| Novus Surgical Consultants | $664.41 | 2025 | |
| Arthrex, INC. | $462.45 | 2025 | |
| Si-Bone, INC. | $301.88 | 2022-2024 | |
| Acumed LLC | $205.36 | 2024 | Acumed, Innate Implant |
| Zimmer Biomet Holdings, INC. | $158.71 | 2019 | |
| Globus Medical, INC. | $129.29 | 2022 | |
| Lifenet Health | $124.77 | 2019 | |
| Depuy Synthes Sales INC. | $105.25 | 2019 | |
| Haemonetics Corporation | $94.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Koury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.